[HTML] mdpi.com

[HTML][HTML] Differential expression of polyamine pathways in human pancreatic tumor progression and effects of polyamine blockade on tumor microenvironment

SP Nakkina, SB Gitto, V Pandey, JG Parikh, D Geerts… - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic cancer has a five-year survival rate of less than 8% and is the
fourth leading cause of cancer death in the United States. Existing therapeutics have failed …
被引用次数：22 相关文章

Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment

SP Nakkina, SB Gitto, V Pandey, JG Parikh… - …, 2021 - search.proquest.com
Pancreatic cancer is the fourth leading cause of cancer death. Existing therapies only
moderately improve pancreatic ductal adenocarcinoma (PDAC) patient prognosis. The …
[PDF] academia.edu

[PDF][PDF] Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment

SP Nakkina, SB Gitto, V Pandey, JG Parikh, D Geerts… - cancer. J, 2017 - academia.edu
Pancreatic cancer is the fourth leading cause of cancer death. Existing therapies only
moderately improve pancreatic ductal adenocarcinoma (PDAC) patient prognosis. The …

Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment

SP Nakkina, SB Gitto, V Pandey, JG Parikh… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Pancreatic cancer is the fourth leading cause of cancer death. Existing therapies only
moderately improve pancreatic ductal adenocarcinoma (PDAC) patient prognosis. The …

Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment.

SP Nakkina, SB Gitto, V Pandey, JG Parikh… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Pancreatic cancer has a five-year survival rate of less than 8%
and is the fourth leading cause of cancer death in the United States. Existing therapeutics …

Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment.

SP Nakkina, SB Gitto, V Pandey, JG Parikh, D Geerts… - Cancers, 2021 - europepmc.org
Pancreatic cancer is the fourth leading cause of cancer death. Existing therapies only
moderately improve pancreatic ductal adenocarcinoma (PDAC) patient prognosis. The …
[HTML] nih.gov

[HTML][HTML] Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment

SP Nakkina, SB Gitto, V Pandey, JG Parikh, D Geerts… - Cancers, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer is the fourth leading cause of cancer death. Existing therapies only
moderately improve pancreatic ductal adenocarcinoma (PDAC) patient prognosis. The …

Differential expression of polyamine pathways in human pancreatic tumor progression and effects of polyamine blockade on tumor microenvironment

SP Nakkina, SB Gitto, V Pandey… - …, 2021 - researchinformation.amsterdamumc …
Pancreatic cancer is the fourth leading cause of cancer death. Existing therapies only mod-
erately improve pancreatic ductal adenocarcinoma (PDAC) patient prognosis. The present …

[引用][C] Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment

SP Nakkina, SB Gitto, V Pandey, JG Parikh… - …, 2021 - mediatum.ub.tum.de
mediaTUM - Medien- und Publikationsserver mediaTUM Universitätsbibliothek Technische
Universität München Logo Benutzer: Gast Login de en mediaTUM Gesamtbestand …

Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment

SP Nakkina, SB Gitto, V Pandey, JG Parikh, D Geerts… - Cancers, 2021 - cir.nii.ac.jp
抄録< jats: p> Pancreatic cancer is the fourth leading cause of cancer death. Existing
therapies only moderately improve pancreatic ductal adenocarcinoma (PDAC) patient …